TY - JOUR
T1 - Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis
AU - Hoving, Jan Lucas
AU - Lacaille, Diane
AU - Urquhart, Donna Michelle
AU - Hannu, Timo J
AU - Sluiter, Judith K
AU - Frings-Dresen, Monique H W
PY - 2014
Y1 - 2014
N2 - Background
Work participation of patients with inflammatory arthritis (IA) is important not only economically but alsofor physical and psychological health. There is no Cochrane Review to date on studies of non-pharmacological interventions specifically aimed at preventing job loss in people with IA.
Objectives
To assess the effects of non-pharmacological interventions that aim to prevent job loss, work absenteeism or improve work functioning for employees with IA (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), other spondylarthritis (SpA) or IA associated with connective tissue diseases, such as Systemic Lupus Erythematosus (SLE)).
Search methods
We searched the following databases from inception up to 30 April 2014; The Cochrane Library (including Cochrane Central Register of Controlled Trials, i.e. CENTRAL and DARE), MEDLINE (PubMed), EMBASE (Embase.com), CINAHL (EbSCOhost), ClinicalTrials.gov and PsycINFO (ProQuest). We did not impose language restrictions in the search.
Selection criteria
We included randomised controlled trials (RCTs) that evaluated interventions aimed at preventing job loss in adults of working age (18 to 65 years) diagnosed with IA, including RA, AS, PsA, SpA or other types of IA. Primary outcomes were job loss and sickness absenteeism and the secondary outcome was work functioning.
AB - Background
Work participation of patients with inflammatory arthritis (IA) is important not only economically but alsofor physical and psychological health. There is no Cochrane Review to date on studies of non-pharmacological interventions specifically aimed at preventing job loss in people with IA.
Objectives
To assess the effects of non-pharmacological interventions that aim to prevent job loss, work absenteeism or improve work functioning for employees with IA (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), other spondylarthritis (SpA) or IA associated with connective tissue diseases, such as Systemic Lupus Erythematosus (SLE)).
Search methods
We searched the following databases from inception up to 30 April 2014; The Cochrane Library (including Cochrane Central Register of Controlled Trials, i.e. CENTRAL and DARE), MEDLINE (PubMed), EMBASE (Embase.com), CINAHL (EbSCOhost), ClinicalTrials.gov and PsycINFO (ProQuest). We did not impose language restrictions in the search.
Selection criteria
We included randomised controlled trials (RCTs) that evaluated interventions aimed at preventing job loss in adults of working age (18 to 65 years) diagnosed with IA, including RA, AS, PsA, SpA or other types of IA. Primary outcomes were job loss and sickness absenteeism and the secondary outcome was work functioning.
UR - http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010208.pub2/pdf
U2 - 10.1002/14651858.CD010208.pub2
DO - 10.1002/14651858.CD010208.pub2
M3 - Article
SN - 1469-493X
VL - 11
SP - 1
EP - 43
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
M1 - CD010208
ER -